News Formal

Vifor Pharma shares jump 15% as takeover talks with CSL confirmed

  • 📰 Reuters
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Vifor Pharma's shares surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL both confirmed they were talking about a potential merger.

Australian media reports have suggested a bid by biopharmaceutical giant CSL for Vifor could result in a A$10 billion deal.

"Until then, Vifor does not comment on these discussions," said the company which works on iron deficiency, nephrology and cardio-renal therapies. A successful deal would be CSL's biggest acquisition and give it access to Vifor's treatments for iron deficiency, kidney and cardio-renal diseases, as well as its production sites in Switzerland and Portugal, analysts said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Britain Increases Scrutiny of Foreign Takeovers as U.S. Deals SurgeThe U.K. is putting foreign takeovers of its businesses under greater scrutiny, complicating a popular route to overseas expansion for American companies as they spend record amounts on British acquisitions. Well yes, when you fly into AU you suddenly are no longer a citizen and get sent to camps.
Source: WSJ - 🏆 98. / 63 Read more »